Anika Therapeutics S.r.l.

Fidia Farmaceutici S.p.a.

Anna Taglienti

Davide Bellini

Vittorio Crescenzi

Cristina Longinotti

Lanfranco Callegaro

Devis Galesso

New biomaterials consisting of a combination of sulphated hyaluronic acid and gellan (as well as gellan that has not been associated with other polymers), to be used as a highly effective barrier to prevent post-surgical adhesions in abdominal, pelvic and, above all, spine surgery.

Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in the prevention of spinal adhesions

The present invention describes a new bioresorbable filler constituted by hyaluronic acid and/or the derivatives thereof structured with/in phospholipid liposomes, which increase the residence time of the starting polymer in situ. Said fillers described herein are substantially intended to increase the soft tissues in aesthetic surgery and dermocosmetics for the correction of mild to medium defects, but because of their special characteristics they can also be used in other fields of application.

Bioresorbable fillers constituted by phospholipid liposomes and hyaluronic acid and/or the derivatives thereof

Growing community of inventors

Rome, Italy

Anna Taglienti